Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals ; day:26 ; month:12 ; year:2022 ; pages:1-19
Clinical pharmacokinetics ; (26.12.2022), 1-19
- Creator
-
Berton, Mattia
Bettonte, Sara
Stader, Felix
Battegay, Manuel
Marzolini, Catia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-022-01194-3
- URN
-
urn:nbn:de:101:1-2023030721274182450286
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Berton, Mattia
- Bettonte, Sara
- Stader, Felix
- Battegay, Manuel
- Marzolini, Catia
- SpringerLink (Online service)
Other Objects (12)
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications